跳至主要内容
临床试验/KCT0004861
KCT0004861已完成未知

Dynamic Contrast Enhanced Magnetic Resonance Imaging Parameters after Radiotherapy for Bone Metastases in Patients with Hepatocellular Carcinoma : A Prospective Study

Samsung Medical Center0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients with hepatocellular carcinoma who were scheduled to
  • undergo radiation therapy for bone metastases were included. Patients were
  • included in the study if they were aged older than 18 years, had been diagnosed
  • to have hepatocellular carcinoma either by histological evaluation or clinical
  • imaging, and have been diagnosed to have metastases in thoracic, lumbosacral
  • vertebra, pelvic bone, or proximal femur. The criteria for considering bone
  • metastasis from hepatocellular carcinoma includes newly developed lesions, clear
  • progression of the lesion revealed from the follow-up examinations, or
  • histopathologic confirmation by bone biopsy if available.

排除标准

  • Patients with history of another primary malignancy, history
  • of surgery, radiation therapy, or metallic instrumentation in thoracic,
  • lumbosacral spine, pelvic bone, or proximal femur, contraindication to
  • gadolinium-based contrast agents or MRI examinations, female patients who are
  • pregnant or nursing.

研究者

相似试验

Dynamic Contrast Enhanced Magnetic Resonance Imaging... | 临床试验